Tokyo Tape
Sign in
← BrightPath Biotherapeutics

Annual report

4594.TEDINET S100VZBU
Period2024-04-01 → 2025-03-31
Filed2025-06-19
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥1m2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥72,0002023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥5m2022-04-01 → 2023-03-31dStandaloneNet sales (5-year summary)
Revenue¥15m2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥3m2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Operating income−¥1.2bn2024-04-01 → 2025-03-31StandaloneOperating income
Operating income−¥1.2bn2023-04-01 → 2024-03-31StandaloneOperating income
Ordinary income−¥1.1bn2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income−¥1.2bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income−¥1.5bn2022-04-01 → 2023-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.5bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.7bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.1bn2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Profit before tax−¥1.2bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Net income−¥1.2bn2024-04-01 → 2025-03-31StandaloneProfit loss
Net income−¥1.2bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income−¥1.5bn2022-04-01 → 2023-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.5bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.7bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Total assets¥1.1bnat 2025-03-31StandaloneAssets
Total assets¥1.2bnat 2024-03-31StandaloneAssets
Total assets¥1.7bnat 2023-03-31dStandaloneTotal assets (5-year summary)
Total assets¥2.8bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.7bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥196mat 2025-03-31StandaloneLiabilities
Total liabilities¥251mat 2024-03-31StandaloneLiabilities
Net assets / equity¥925mat 2025-03-31StandaloneNet assets
Net assets / equity¥979mat 2024-03-31StandaloneNet assets
Net assets / equity¥1.6bnat 2023-03-31dStandaloneNet assets
Net assets / equity¥2.5bnat 2022-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥3.5bnat 2021-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥810mat 2025-03-31StandaloneCash and deposits
Cash and deposits¥1.1bnat 2024-03-31StandaloneCash and deposits
Cash & equivalents¥810mat 2025-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2023-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.3bnat 2021-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.3bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.5bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.8bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥1m2024-04-01 → 2025-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥8m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥2m2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥18m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥36m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.0bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥691m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥432m2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥569m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥2.1bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-14.122024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.212023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-24.92022-04-01 → 2023-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-28.552021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.142020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥9.98at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥13.52at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥24.6at 2023-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥45.4at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥69.1at 2021-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio80.6%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.7%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.9%at 2023-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio90.5%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio93.7%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued90,491,300at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued70,741,300at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued62,891,200at 2023-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued55,253,100at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued50,817,500at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees24at 2025-03-31StandaloneNumber of employees
Employees24at 2024-03-31StandaloneNumber of employees
Employees32at 2023-03-31dStandaloneNumber of employees
Employees38at 2022-03-31dStandaloneNumber of employees
Employees44at 2021-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 742
ItemContextValueUnit
Independent auditors report non consolidated (text)FilingDateInstantText · Plus
Audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)EY新日本有限責任監査法人
Cpa1 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)奥　　見　　正　　浩
Cpa2 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)田 中　 友 康
Key audit matters non consolidated (text)FilingDateInstantText · Plus
Overview kam non consolidated (text)FilingDateInstantText · Plus
Short description kam non consolidatedFilingDateInstant_Row1Member
Original text (Japanese)継続企業の前提に関する経営者の対応策の評価
Description including reason kam non consolidated (text)FilingDateInstant_Row1MemberText · Plus
Auditors response kam non consolidated (text)FilingDateInstant_Row1MemberText · Plus
Short description kam non consolidatedFilingDateInstant_Row2Member
Original text (Japanese)研究開発費のうち外部委託に係る費用の期間帰属
Description including reason kam non consolidated (text)FilingDateInstant_Row2MemberText · Plus
Auditors response kam non consolidated (text)FilingDateInstant_Row2MemberText · Plus
Other information non consolidated (text)FilingDateInstantText · Plus
Fee related information non consolidated (text)FilingDateInstantText · Plus
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior4YearDuration_NonConsolidatedMember2504000JPY
Net sales (5-year summary)Prior3YearDuration_NonConsolidatedMember15408000JPY
Net sales (5-year summary)Prior2YearDuration_NonConsolidatedMember5280000JPY
Net sales (5-year summary)Prior1YearDuration_NonConsolidatedMember72000JPY
Net sales (5-year summary)CurrentYearDuration_NonConsolidatedMember1133000JPY
Ordinary income loss (5-year summary)Prior4YearDuration_NonConsolidatedMember-1738636000JPY
Ordinary income loss (5-year summary)Prior3YearDuration_NonConsolidatedMember-1481945000JPY
Ordinary income loss (5-year summary)Prior2YearDuration_NonConsolidatedMember-1473774000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember-1158929000JPY
Ordinary income loss (5-year summary)CurrentYearDuration_NonConsolidatedMember-1147879000JPY
Net income loss (5-year summary)Prior4YearDuration_NonConsolidatedMember-1719634000JPY
Net income loss (5-year summary)Prior3YearDuration_NonConsolidatedMember-1484192000JPY
Net income loss (5-year summary)Prior2YearDuration_NonConsolidatedMember-1485633000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember-1168082000JPY
Net income loss (5-year summary)CurrentYearDuration_NonConsolidatedMember-1151149000JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior4YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior3YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior2YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)CurrentYearDuration_NonConsolidatedMember－JPY
Capital stock (5-year summary)Prior4YearInstant_NonConsolidatedMember6459712000JPY
Capital stock (5-year summary)Prior3YearInstant_NonConsolidatedMember6700382000JPY
Capital stock (5-year summary)Prior2YearInstant_NonConsolidatedMember362185000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember650661000JPY
Capital stock (5-year summary)CurrentYearInstant_NonConsolidatedMember1199869000JPY
Total number of issued shares (5-year summary)Prior4YearInstant_NonConsolidatedMember50817500
Total number of issued shares (5-year summary)Prior3YearInstant_NonConsolidatedMember55253100
Total number of issued shares (5-year summary)Prior2YearInstant_NonConsolidatedMember62891200
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember70741300
Total number of issued shares (5-year summary)CurrentYearInstant_NonConsolidatedMember90491300
Net assets (5-year summary)Prior4YearInstant_NonConsolidatedMember3537642000JPY
Net assets (5-year summary)Prior3YearInstant_NonConsolidatedMember2531475000JPY
Net assets (5-year summary)Prior2YearInstant_NonConsolidatedMember1567541000JPY
Net assets (5-year summary)Prior1YearInstant_NonConsolidatedMember978987000JPY
Net assets (5-year summary)CurrentYearInstant_NonConsolidatedMember924987000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-03-31pass
balance sheet identitynon_consolidated 2025-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flownon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass